Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Infectious Disease

What Do Rising Hematocrit & Low Platelets Mean in Dengue?

At a Glance

In Dengue fever, a rising hematocrit combined with dropping platelets indicates you are entering the dangerous critical phase. This pattern means fluid is leaking from your blood vessels while your blood's ability to clot decreases, requiring close medical monitoring and fluid therapy.

When you look at your daily lab reports during Dengue fever, seeing your hematocrit go up while your platelets go down is a critical warning sign indicating that you may be entering the critical phase of the disease [1][2]. This combination means your blood vessels have become “leaky,” causing the liquid part of your blood to escape into your body tissues, while your blood’s ability to clot is dropping [3][4]. Because this can lead to dangerously low blood pressure, this pattern strongly signals that your medical team will need to closely monitor you and may initiate fluid therapies to keep your body stable [5][6].

What a Rising Hematocrit Means

Your hematocrit measures the concentration of your blood—specifically, what percentage of your blood is made up of red blood cells.

Normally, your blood is a balanced mixture of liquid (called plasma) and solid cells. However, the Dengue virus can damage your blood vessels, causing them to act like a leaky hose [7]. When the watery plasma leaks out of the vessels and into your body, the red blood cells get left behind [8].

As a result, your blood becomes thicker and more concentrated—a condition called hemoconcentration [9]. A rising hematocrit does not mean your body is making extra blood cells; it means you are losing the vital fluid that normally dilutes them [10][3]. Because normal hematocrit levels vary by age and sex, doctors look closely at the trend. A rapid hematocrit increase—often of 20% or more from your normal baseline—is a hallmark sign of this fluid leakage [11].

Why Platelets are Dropping

Platelets are the tiny cells in your blood responsible for forming clots and preventing bleeding.

During Dengue fever, the virus and your immune system’s response to it cause a sharp decline in your platelet count (thrombocytopenia) [3]. A rapid drop in platelets almost always accompanies or immediately precedes the period when your blood vessels start to leak [12]. When your platelets drop dangerously low, you are at a higher risk for bruising and internal or external bleeding [1].

Important Safety Note: Because your bleeding risk is elevated, it is vital to avoid medications like NSAIDs (ibuprofen, aspirin, naproxen) which can worsen bleeding. If you need pain or fever relief, doctors typically recommend acetaminophen (paracetamol) instead.

The Danger of the “Critical Phase”

The period when plasma leakage occurs is known as the critical phase of Dengue fever [13]. Paradoxically, this phase usually begins right around the time your fever breaks (defervescence), typically between the 3rd and 7th day of your illness [14][2]. Many people mistakenly believe they are getting better because their temperature is dropping, but this is actually when the risk is highest.

To catch this critical window, your care team will likely require daily or even more frequent blood tests to monitor your changing hematocrit and platelet numbers. If too much fluid leaks out of your bloodstream and is not replaced, there won’t be enough volume left to pump oxygen to your organs. This can lead to Dengue Shock Syndrome—a severe complication where your circulatory system collapses [15][16].

Managing the Fluid Leak

If your labs show this dangerous pattern, your medical team will intervene to maintain your blood volume [5]. Often, the first step is intense oral rehydration therapy. You will be encouraged to drink plenty of oral rehydration salts (ORS), milk, or juices to replace the lost fluid.

However, if you cannot drink enough fluids, or if the plasma leak is severe, your doctor will start intravenous (IV) fluid therapy [17][6]. The goal of IV fluids is to carefully pump liquid back into your veins to keep your blood pressure stable while supporting your circulatory system for the 24 to 48 hours it takes for the blood vessels to heal and stop leaking [2].

Warning Signs to Watch For

Your lab work gives doctors a look inside your body, but you should also be highly alert to physical warning signs of the critical phase. Seek immediate medical attention if you experience:

  • Severe or continuous abdominal pain [18]
  • Persistent vomiting [19]
  • Extreme lethargy, restlessness, or exhaustion [20]
  • Bleeding from your nose or gums, or blood in your vomit or stool [1]
  • Difficulty breathing (which can happen if fluid leaks into the chest area) [2]

Common questions in this guide

Why does my hematocrit go up during Dengue fever?
Hematocrit goes up because the Dengue virus damages your blood vessels, causing the watery part of your blood to leak into your body tissues. This leaves your red blood cells behind, making your blood thicker and more concentrated.
Why do platelets drop during Dengue fever?
Platelets drop sharply due to the virus and your immune system's response to it. This drop typically happens right before or during the phase when your blood vessels start to leak, significantly increasing your risk of bruising and bleeding.
What is the critical phase of Dengue fever?
The critical phase is a dangerous period that usually starts when your fever breaks, around the 3rd to 7th day of illness. During this time, plasma leaks from your blood vessels, which can lead to dangerously low blood pressure or circulatory collapse if not managed.
Can I take ibuprofen or aspirin during Dengue fever?
No, you should strictly avoid NSAIDs like ibuprofen, aspirin, and naproxen during a Dengue infection. Because your platelet count is low, these medications can worsen your risk of bleeding. Doctors typically recommend acetaminophen (paracetamol) instead.
What are the emergency warning signs during Dengue fever?
You should seek emergency medical care if you experience severe abdominal pain, persistent vomiting, extreme exhaustion, difficulty breathing, or any unusual bleeding from your nose, gums, or in your stool or vomit.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my baseline hematocrit, and how much has it gone up today?
  2. 2.Are my current lab results at the point where I need to be admitted to the hospital for IV fluids, or can I manage this with oral hydration at home?
  3. 3.How often will we be rechecking my complete blood count (CBC) to monitor my platelets and hematocrit?
  4. 4.Are there any clinical signs of fluid accumulating in my lungs or abdomen during this critical phase?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Dengue hemorrhagic fever and the liver.

    Leowattana W, Leowattana T

    World journal of hepatology 2021; (13(12)):1968-1976 doi:10.4254/wjh.v13.i12.1968.

    PMID: 35070001
  2. 2

    Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement.

    de Almeida RR, Paim B, de Oliveira SA, et al.

    Lung 2017; (195(4)):389-395 doi:10.1007/s00408-017-0021-6.

    PMID: 28612239
  3. 3

    Gall Bladder Wall Thickening in Dengue Fever - Aid in Labelling Dengue Hemorrhagic Fever and a Marker of Severity.

    Adil B, Rabbani A, Ahmed S, et al.

    Cureus 2020; (12(11)):e11331 doi:10.7759/cureus.11331.

    PMID: 33304669
  4. 4

    Predictive Factors for the Complications of Dengue Fever in Children: A Retrospective Analysis.

    Uthraraj NS, Sriraam LM, Hiriyur Prakash M, et al.

    Cureus 2022; (14(12)):e33027 doi:10.7759/cureus.33027.

    PMID: 36721616
  5. 5

    Concurrent Typhoid Fever and Dengue Hemorrhagic Fever: A Case Report.

    Khalid A, Ur Rehman A, Baig A, et al.

    Cureus 2022; (14(8)):e28600 doi:10.7759/cureus.28600.

    PMID: 36185892
  6. 6

    Lessons learnt from managing a case of dengue hemorrhagic fever complicated with acute liver failure and acute kidney injury: a case report.

    Dalugama C, Gawarammana IB

    Journal of medical case reports 2018; (12(1)):215 doi:10.1186/s13256-018-1766-0.

    PMID: 30089506
  7. 7

    Effects of dengue virus type-2 serotype (DENV-2) on the expression profile of matrix metalloproteinases in THP-1, monocyte cells and their roles in endothelial dysfunctions: protective effect of atorvastatin.

    Niranjan R, Vidhyapriya P, Murugasamy V, et al.

    Frontiers in cellular and infection microbiology 2025; (15()):1632634 doi:10.3389/fcimb.2025.1632634.

    PMID: 41189711
  8. 8

    Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.

    Wang WH, Urbina AN, Chang MR, et al.

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2020; (53(6)):963-978 doi:10.1016/j.jmii.2020.03.007.

    PMID: 32265181
  9. 9

    Impact of Nutritional Status on the Severity of Dengue Infection Among Pediatric Patients in Southern Thailand.

    Maneerattanasak S, Suwanbamrung C

    The Pediatric infectious disease journal 2020; (39(12)):e410-e416 doi:10.1097/INF.0000000000002839.

    PMID: 32773668
  10. 10

    Dengue hemorrhagic fever: a growing global menace.

    Parveen S, Riaz Z, Saeed S, et al.

    Journal of water and health 2023; (21(11)):1632-1650 doi:10.2166/wh.2023.114.

    PMID: 38017595
  11. 11

    In Silico Optimization of a Non-Invasive Optical Sensor for Hemoconcentration Monitoring in Dengue Fever Management.

    Althobaiti M, Saleh G

    Biosensors 2026; (16(2)) doi:10.3390/bios16020121.

    PMID: 41744739
  12. 12

    Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients.

    Tsai JJ, Chang JS, Chang K, et al.

    Biomedicine hub 2017; (2(1)):1-16 doi:10.1159/000457785.

    PMID: 31988894
  13. 13

    Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.

    Her Z, Kam YW, Gan VC, et al.

    The Journal of infectious diseases 2017; (215(1)):42-51 doi:10.1093/infdis/jiw494.

    PMID: 28077582
  14. 14

    Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection.

    Cui L, Pang J, Lee YH, et al.

    PLoS neglected tropical diseases 2018; (12(1)):e0006217 doi:10.1371/journal.pntd.0006217.

    PMID: 29364889
  15. 15

    Immunologic Crosstalk and Host-Specific Immune Signature Associated with Dengue.

    Palmal S, Kundu S, Ganguly S, et al.

    ACS omega 2024; (9(36)):37418-37429 doi:10.1021/acsomega.4c02506.

    PMID: 39281909
  16. 16

    The Difference of sVE-Cadherin Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock.

    Mariko R, Darwin E, Yanwirasti Y, Hadinegoro SR

    Open access Macedonian journal of medical sciences 2019; (7(14)):2277-2281 doi:10.3889/oamjms.2019.602.

    PMID: 31592274
  17. 17

    Early intervention of 5% albumin shown superior control of vascular integrity and function compared to ringer's lactatein hospitalized adult with grade I & II Dengue hemorrhagic fever: a multicenter randomized controlled trial in Indonesia.

    Bur R, Suwarto S, Pohan HT, et al.

    Tropical diseases, travel medicine and vaccines 2024; (10(1)):20 doi:10.1186/s40794-024-00230-3.

    PMID: 39350232
  18. 18

    Use of structural equation models to predict dengue illness phenotype.

    Park S, Srikiatkhachorn A, Kalayanarooj S, et al.

    PLoS neglected tropical diseases 2018; (12(10)):e0006799 doi:10.1371/journal.pntd.0006799.

    PMID: 30273334
  19. 19

    Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital-Based Cross-Sectional Study.

    Hossain MJ, Das M, Shahjahan M, et al.

    Health science reports 2025; (8(1)):e70356 doi:10.1002/hsr2.70356.

    PMID: 39831075
  20. 20

    Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia.

    Dussart P, Duong V, Bleakley K, et al.

    PLoS neglected tropical diseases 2020; (14(9)):e0008603 doi:10.1371/journal.pntd.0008603.

    PMID: 32925941

This page explains Dengue fever laboratory results for educational purposes only. Always consult a healthcare provider to interpret your specific blood tests, monitor your hydration, and manage your symptoms.

Get notified when new evidence is published on Dengue fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.